Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian High Grade Serous Adenocarcinoma 1 Medulloblastoma 1 Locally Advanced Non-Small Cell Lung Cancer 1 Leukemia, Myeloid, Acute 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 42 Magnetic Resonance Spectroscopy 41 Radiotherapy 22 Specimen Handling 18 Biopsy 13 X-Rays 10 Radiation 10 trametinib 8 Bevacizumab 8 Nivolumab 7 Blood Specimen Collection 7 olaparib 6 fluorodopa F 18 6 dabrafenib 6 Radiotherapy, Intensity-Modulated 6 Phantoms, Imaging 6 Nuclear Medicine Department, Hospital 6 Lomustine 6 pembrolizumab 5 abemaciclib 5 Standard of Care 5 vorasidenib 4 ulixertinib 4 larotrectinib 4 ivosidenib 4 erdafitinib 4 Surgical Procedures, Operative 4 Dianhydrogalactitol 4 Cyclophosphamide 4 Aminolevulinic Acid 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Atovaquone × 1 year × Clear all

NCT06624371 2025-07-22

AflacBT2303

Emory University

Phase 1 Recruiting

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡